Vg Life Sciences Inc
13F holders, Q1 2026 (March 31)1holders
$0.00avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Vg Life Sciences Inc in their 13F filings. The largest holder was Hanson & Doremus Investment Management ($0).
- Company
- Vg Life Sciences Inc
- CUSIP
- 91822T101
- Latest filing quarter
- Q1 2026
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Hanson & Doremus Investment Management | 0.00% | New | 67 | $0 |
"% of holder's portfolio" is Vg Life Sciences Inc's weight in each manager's 13F, not the share of Vg Life Sciences Inc the manager owns.